指南与共识细菌感染、耐药与抗菌药物

越南社区获得性呼吸道感染背景下的抗菌药物耐药性国家数据:抗生素敏感性、本地与国际抗生素处方指南、药物可及性与临床结局之间的联系

Country data on AMR in Vietnam in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicines and clinical outcome.
指南 / 共识 · J Antimicrob Chemother · 2022-01-01

该综述梳理了越南抗菌药物耐药性(AMR)现状及相关举措,重点回顾肺炎链球菌和流感嗜血杆菌等社区获得性呼吸道感染(CA-RTI)病原体的药敏数据、本地与国际处方指南及抗生素可及性。越南是西太平洋区域首个制定国家抗AMR行动计划的国家,但AMR率居亚洲前列,与动物和人类抗菌药物过度使用及非处方获取有关。作者认为采用越南社区感染分离株的最新监测数据制定本地指南,可提高处方适当性和依从性。

要点

  • 越南是西太平洋区域首个制定国家抗AMR行动计划的国家,据WHO该计划正在实施中。
  • 越南AMR率居亚洲前列,部分源于动物和人类抗菌药物过度使用,且存在非处方获取抗生素。
  • SOAR和SENTRY等全球监测研究提供越南CA-RTI病原体药敏数据,SENTRY仅含少量分离株。

核心结论

  • 越南已采取一些应对AMR的举措,但AMR率仍居亚洲前列,部分源于动物和人类抗菌药物过度使用。
  • 尽管2005年法律要求抗生素处方,但非处方抗生素获取不受限制。
  • 采用越南社区感染分离株的最新监测数据、以更标准化包容性方法制定本地指南,可使指南更贴合本地临床,促进更适当处方和依从性,从而可能限制AMR发展并改善患者结局。

研究设计与样本

  • 该文为综述,识别了越南应对AMR的国家举措、抗生素使用与处方、药敏数据可及性,重点为肺炎链球菌和流感嗜血杆菌等CA-RTI病原体。
  • 综述还回顾了当地常用的CA-RTI(社区获得性肺炎、急性中耳炎、急性细菌性鼻窦炎)国家与国际抗生素处方指南及本地抗生素可及性。
  • 并征求越南临床医生意见以对信息进行情境化解读。

主要发现

  • 越南是西太平洋区域首个制定国家抗AMR行动计划的国家,据WHO该计划正在实施。
  • 越南AMR率居亚洲前列,部分源于动物卫生领域和人类(医院与社区)抗菌药物过度使用。
  • 尽管2005年法律要求抗生素处方,但非处方抗生素获取不受限制。
  • SOAR和SENTRY等全球监测研究提供越南CA-RTI病原体药敏数据,SENTRY仅含少量分离株。
  • 专家临床意见确认常见呼吸道病原体耐药率高。

关键数值与推荐

  • 越南存在若干国家特定本地抗生素处方指南,并参考多种国际指南,但国际指南可能基于与越南差异很大的病原体耐药模式制定。

临床怎么用

  • 作者认为,采用越南社区感染分离株的最新监测数据、以更标准化包容性方法制定本地指南,可使管理指南对临床医生更具本地相关性。

局限性

  • SENTRY仅含少量分离株。
  • 国际指南可能基于与越南差异很大的病原体耐药模式制定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antimicrobial resistance (AMR) is one of the biggest threats to global public health. Selection of resistant bacteria is driven by inappropriate use of antibiotics, amongst other factors. COVID-19 may have exacerbated AMR due to unnecessary antibiotic prescribing. Country-level knowledge is needed to understand options for action. OBJECTIVES: To review the current situation with respect to AMR in Vietnam and initiatives addressing it. Identifying areas where more information is required will provide a call to action to minimize any further rises in AMR within Vietnam and improve patient outcomes. METHODS: National initiatives to address AMR in Vietnam, antibiotic use and prescribing, and availability of susceptibility data, in particular for the key community-acquired respiratory tract infection (CA-RTI) pathogens Streptococcus pneumoniae and Haemophilus influenzae, were identified. National and international antibiotic prescribing guidelines for CA-RTIs (community-acquired pneumonia, acute otitis media and acute bacterial rhinosinusitis) commonly used locally were also reviewed, plus local antibiotic availability. Insights from clinicians in Vietnam were sought to contextualize this information. CONCLUSIONS: In Vietnam there have been some initiatives addressing AMR; Vietnam was the first country in the Western Pacific Region to develop a national action plan to combat AMR, which according to the WHO is being implemented. Vietnam also has one of the highest rates of AMR in Asia due, in part, to the overuse of antimicrobial drugs, both in the animal health sector and in humans in both hospitals and the community. In addition, despite a 2005 law requiring antibiotic prescription, there is unrestricted access to over-the-counter antibiotics. Several global surveillance studies provide antibiotic susceptibility data for CA-RTI pathogens in Vietnam including Survey of Antibiotic Resistance (SOAR) and SENTRY (small isolate numbers only). For management of the common CA-RTIs in Vietnam there are several country-specific local antibiotic prescribing guidelines and in addition, there is a range of international guidelines referred to, but these may have been created based on pathogen resistance patterns that might be very different to those in Vietnam. Expert clinician opinion confirms the high resistance rates among common respiratory pathogens. A more standardized inclusive approach in developing local guidelines, using up-to-date surveillance data of isolates from community-acquired infections in Vietnam, could make management guideline use more locally relevant for clinicians. This would pave the way for a higher level of appropriate antibiotic prescribing and improved adherence. This would, in turn, potentially limit AMR development and improve clinical outcomes for patients.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Torumkuney D, Kundu S, Vu GV, et al. Country data on AMR in Vietnam in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicines and clinical outcome. J Antimicrob Chemother. 2022. PMID: 36065731. doi:10.1093/jac/dkac214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。